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Angiotensin 
blockade reverses 
nephrosclerosis
Th e principal mechanism for 
progression of renal disease is thought 
to be mediated by angiotensin II. 
Blockade of this system clearly 
prevents progression. Th e question, 
however, is whether continuous 
blockade of this system allows repair 
or regression of glomerular sclerosis. 
To investigate this question, Remuzzi 
et al. induced renal disease in Munich-
Wistar rats that spontaneously develop 
glomerulosclerosis and proteinuria 
during their lifespans. Angiotensin-
converting enzyme (ACE) inhibition 
almost normalized proteinuria and 
stabilized serum creatinine. Th e 
authors performed serial sections and 
reconstruction of glomeruli to examine 
the level of glomerulosclerosis. In 
untreated animals, they found that 
the whole glomerular tuft  of most 
glomeruli became aff ected, and the 
fi brosis was progressive with age (60 
weeks). ACE inhibition begun late 
in the disease reduced the incidence 
and extent of glomerulosclerosis, with 
almost one-quarter of the glomeruli 
being unaff ected. Importantly, during 
treatment, neither glomerular volume 
nor mass was aff ected; this suggests 
that there was some regeneration of 
glomerular tissue. Whereas untreated 
animals consistently lost glomerular 
volume, treated rats increased their 
fraction of unfi brosed glomerular 
capillaries. Th ese results raise the 
tantalizing conclusion that ACE 
Patients who had the highest levels of 
IgA had more hematuria, but not when 
creatinine levels or proteinuria were 
measured. Whether secretory IgA 
has a pathogenic role in this form of 
nephropathy will need to be proven in 
further studies. But the accumulation 
of secretory IgA and its potency in the 
induction of infl ammatory mediators 
make this subject worth pursuing. See 
page 1131. 
Macrophage invasion 
and urinary MCP1 
excretion in human 
glomerular disease
Tubulo-interstitial disease is now 
seen as one of the worst prognostic 
factors in progression of renal failure 
in a variety of glomerular diseases. 
One major cause of interstitial 
infl ammation and fi brosis is likely to 
be the eff ect of proteinuria on tubular 
expression of infl ammatory mediators 
such as monocyte chemoattractant 
protein-1 (MCP1), which induce the 
invasion of macrophages into the 
renal interstitium. As they report 
in this issue, Eardley et al. studied a 
large number of patients with various 
glomerular diseases who underwent 
renal biopsies. Th ey found that 
MCP1 excretion correlated with the 
extent of proteinuria and interstitial 
macrophage invasion, as well as with 
interstitial fi brosis. Th ese correlations 
were strongest in early phases of the 
diseases before extensive fi brosis had 
set in. When the same studies were 
performed in patients with ischemic 
nephropathy, there was little if any 
correlation between these parameters. 
Animal studies have previously shown 
that knockout of MCP1 protects mice 
from induced glomerular disease. Th e 
present study suggests that MCP1 and 
macrophage invasion might play an 
important role in human glomerular 
disease. See page 1189.
inhibition can induce regression of 
structural lesions with regeneration 
of normal glomerular capillary 
tissue. Th ese results have important 
implications for the impact of ACE 
inhibitor therapy on the development 
of end-stage renal disease. See 
page 1124.
Secretory 
immunoglobulin A in 
glomerular deposits
Immunoglobulin A (IgA), which 
exists as a polymeric protein in 
circulation, binds to its receptor on 
the basolateral membrane of many 
epithelia and is internalized with the 
receptor. Vesicles carrying IgA then 
move to the apical surface. During 
this traffi  cking process, a protease 
located in the vesicles clips external 
domain of the receptor. Th e antibody 
and receptor complex is then secreted 
into the lumen of many organs, such 
as the respiratory and gastrointestinal 
tracts. Th e clipped receptor used to be 
termed the ‘secretory component’ and 
the ‘secretory IgA form’. Polymeric IgA 
and its receptor are oft en found in the 
serum as well as in secretions, though 
their concentration in the serum 
is very low. Oortwijn et al. studied 
a patient with IgA nephropathy, a 
disease characterized by deposits 
of IgA in the renal mesangium. In a 
patient with severe IgA nephropathy 
who underwent nephrectomy, the 
authors eluted IgA components from 
the kidney and found that there was 
120 times more secretory IgA than 
polymeric IgA in these kidneys. 
Using mesangial cells in culture, the 
authors found that secretory IgA 
bound to the cells and was more 
potent than polymeric IgA in inducing 
the secretion of interleukin-6, an 
infl ammatory mediator. Studies on 
the serum concentration of secretory 
IgA in patients with IgA nephropathy 
did not show any signifi cant changes. 
